Development of <i>Kras</i> mutant lung adenocarcinoma in mice with knockout of the airway lineage‐specific gene <scp><i>G</i></scp><i>prc5a</i>
Junya Fujimoto(The University of Texas MD Anderson Cancer Center), Humam Kadara(The University of Texas MD Anderson Cancer Center)
Cited by 28
Related Papers
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
|Cancer Cell|2021|930
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up
|Annals of Oncology|2016|209
Insights Into Lung Cancer Immune-Based Biology, Prevention, and Treatment
|Frontiers in Immunology|2020|130
Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma
|Cancer Research|2017|125
The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network
|Journal of Clinical Investigation|2018|72